Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Delaney

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|January 22, 2014
A randomised controlled trial of supervised exercise regimens and their impact on walking performance, skeletal muscle mass and calpain activity in patients with intermittent claudicationC L Delaney, M D Miller, T K Chataway, et al.
Molecular and Cellular Endocrinology|February 13, 2001
IGF-I promotes Schwann cell motility and survival via activation of AktH L Cheng, M Steinway, C L Delaney, et al.
Biochemical and Biophysical Research Communications|April 15, 1992
Venous smooth muscle contains vasoconstrictor ETB-like receptorsS Moreland, D M McMullen, C L Delaney, et al.
Clinical Nutrition ESPEN|May 23, 2017
Estimating energy expenditure in vascular surgery patients: Are predictive equations accurate enough?J Suen, J M Thomas, C L Delaney, et al.
Biochemical and Biophysical Research Communications|June 30, 1992
The endothelin receptor antagonist, BQ-123, inhibits angiotensin II-induced contractions in rabbit aortaM L Webb, K E Dickinson, C L Delaney, et al.
Clinical Pharmacology and Therapeutics|October 3, 2000
Disposition and safety of omapatrilat in subjects with renal impairmentD A Sica, W Liao, T W Gehr, et al.
Bioorganic & Medicinal Chemistry|July 1, 1993
Structure-activity studies of endothelin leading to novel peptide ETA antagonistsJ T Hunt, V G Lee, D McMullen, et al.
The Annals of Pharmacotherapy|June 16, 1999
Fosinopril and hydrochlorothiazide combination versus individual components: lack of a pharmacokinetic interactionH D Uderman, D R Much, J Brennan, et al.
British Journal of Pharmacology|September 1, 1994
BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174K E Dickinson, R B Cohen, S Skwish, et al.
Journal of Medicinal Chemistry|August 6, 1993
Quinoxaline N-oxide containing potent angiotensin II receptor antagonists: synthesis, biological properties, and structure-activity relationshipsK S Kim, L Qian, J E Bird, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|January 22, 2014
A randomised controlled trial of supervised exercise regimens and their impact on walking performance, skeletal muscle mass and calpain activity in patients with intermittent claudicationC L Delaney, M D Miller, T K Chataway, et al.
Molecular and Cellular Endocrinology|February 13, 2001
IGF-I promotes Schwann cell motility and survival via activation of AktH L Cheng, M Steinway, C L Delaney, et al.
Biochemical and Biophysical Research Communications|April 15, 1992
Venous smooth muscle contains vasoconstrictor ETB-like receptorsS Moreland, D M McMullen, C L Delaney, et al.
Clinical Nutrition ESPEN|May 23, 2017
Estimating energy expenditure in vascular surgery patients: Are predictive equations accurate enough?J Suen, J M Thomas, C L Delaney, et al.
Biochemical and Biophysical Research Communications|June 30, 1992
The endothelin receptor antagonist, BQ-123, inhibits angiotensin II-induced contractions in rabbit aortaM L Webb, K E Dickinson, C L Delaney, et al.
Clinical Pharmacology and Therapeutics|October 3, 2000
Disposition and safety of omapatrilat in subjects with renal impairmentD A Sica, W Liao, T W Gehr, et al.
Bioorganic & Medicinal Chemistry|July 1, 1993
Structure-activity studies of endothelin leading to novel peptide ETA antagonistsJ T Hunt, V G Lee, D McMullen, et al.
The Annals of Pharmacotherapy|June 16, 1999
Fosinopril and hydrochlorothiazide combination versus individual components: lack of a pharmacokinetic interactionH D Uderman, D R Much, J Brennan, et al.
British Journal of Pharmacology|September 1, 1994
BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174K E Dickinson, R B Cohen, S Skwish, et al.
Journal of Medicinal Chemistry|August 6, 1993
Quinoxaline N-oxide containing potent angiotensin II receptor antagonists: synthesis, biological properties, and structure-activity relationshipsK S Kim, L Qian, J E Bird, et al.
Pageof 3